Skip to main content
OpenTrials
Completed

NCT Number: NCT05835323

Initial Clinical Experience With the MONARCH Platform, Urology for the Treatment of Kidney Stones

The purpose of this study is to collect descriptive performance data using the MONARCH Platform, Urology (a novel robotic device) to perform mini-percutaneous nephrolithotomy (kidney stone removal) procedures. Data gathered from this study will be used to optimize the robotic platform and inform training and education material for the future users.

Completed

Looking for future studies?

Notify Me

Key information

Age range

22 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of California - Irvine Medical Center

Orange, California, 92868, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Simple renal caliceal and/or pyelo stone(s), greater than or equal to (>=) 10 millimeter in size identified on computerized tomography (CT) scan, and appropriate for Percutaneous nephrolithotomy (PCNL) treatment according to American Urological Association (AUA) guidelines
  • Normal upper tract anatomy, amenable to PCNL and ureteroscopy
  • Body mass index less than (<) 40 kilogram-meter squared
  • Participants with a percutaneous tract length <15 centimeter as measured by the estimation of the skin to stone or skin to appropriate calyx for treatment through a CT scan
  • Participant is an appropriate candidate for a mini-PCNL based on the clinical guidelines and investigator assessment

Pre-Operative Exclusion Criteria:

  • Any medical or physical condition/limitation that would contraindicate a conventional ureteroscopy or PCNL [for example, atypical interposition of visceral organs (bowel, spleen, or liver)] in the supine position. This assessment will be made by the investigator team
  • Participation in any other clinical trial 30-days before and throughout the duration of the study that might impact the results
  • A solitary functioning kidney
  • Female subjects who are pregnant or nursing or those of childbearing potential refusing a pregnancy test
  • Presence of ureteral impacted stones
  • Presence of ureteral obstruction
  • Presence of untreated urinary tract infection, urosepsis
  • Inability to give consent
  • Presence of a renal mass which has not been investigated
  • Staghorn stone
  • Participant has an electrically or magnetically activated implanted medical device
  • Significant pharmacological anticoagulant therapy or uncorrected bleeding diathesis
  • Tumor in the probable access tract area and potential malignant renal tumor

Intra-Procedure Exclusion Criteria:

  • Any presenting condition discovered intra procedurally that in the opinion of the investigator would make participating in this study not in the participant's best interest. For example, participants no longer considered good candidates for a mini-PCNL procedure for the removal of the kidney stones.

Treatment and study plan

Robotic-assisted mini-PCNL

Device

Eligible participants will be enrolled to undergo robotic-assisted PCNL using the MONARCH Platform, Urology for the removal of kidney stones. The MONARCH Platform, Urology is a novel flexible robotic device that enables the clinician to obtain both transurethral and percutaneous access to a participant's kidney under continuous visualization for therapeutic application (for example, stone removal).

Primary outcomes

  1. Completion of the Robotic Assisted Mini-PCNL Kidney Stone Removal Procedure.

    Time frame: Day of Procedure

    Percentage of participants in whom the kidney stone treatment and removal procedure could be successfully completed with the MONARCH™ Platform, Urology.

Sponsors and collaborators

Lead sponsor

Auris Health, Inc.

Industry

Registry information

Official study title

Initial Experience of the Treatment of Kidney Stones With the MONARCH™ Platform, Urology

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Apr 28, 2023
Registry last updated
Jul 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.